Current report filing

Schedule I - Condensed Statements of Cash Flows (Details)

v3.21.2
Schedule I - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:                      
Net (loss) income $ (302,434) $ 7,514 $ 15,925 $ 224 $ 19,103 $ 26,704 $ 30,578 $ 3,154 $ (278,771) $ 79,539 $ 58,300
Adjustments to reconcile net income to net cash provided by operating activities:                      
Stock compensation expense                 17,194 13,281 16,899
Net cash provided by operating activities                 223,598 267,763 248,644
Cash flows from investing activities:                      
Distribution from subsidiaries                 40,000 40,000 40,000
Net cash provided by investing activities                 (551,472) 35,359 119,290
Cash flows from financing activities:                      
Net cash used in financing activities                 (722,820) (216,093) (137,225)
Cash, cash equivalents and restricted cash at beginning of period       36,125       27,397 36,125 27,397  
Cash, cash equivalents and restricted cash at end of period of continuing operations 113,377       36,125       113,377 36,125 27,397
Parent Company [Member]                      
Cash flows from operating activities:                      
Net (loss) income                 (278,771) 79,539 58,300
Adjustments to reconcile net income to net cash provided by operating activities:                      
Equity in net income from subsidiaries                 253,571 (97,764) (77,764)
Stock compensation expense                 25,200 18,225 19,464
Net cash provided by operating activities                 0 0 0
Cash flows from investing activities:                      
Distribution from subsidiaries                 243,779 0 0
Net cash provided by investing activities                 243,779 0 0
Cash flows from financing activities:                      
Dividends paid to stockholders                 (243,779) 0 0
Net cash used in financing activities                 (243,779) 0 0
Effect of exchange rate changes on cash, cash equivalents and restricted cash                 0 0 0
Net change in cash, cash equivalents and restricted cash                 0 0 0
Cash, cash equivalents and restricted cash at beginning of period       $ 0       $ 0 0 0 0
Cash, cash equivalents and restricted cash at end of period of continuing operations $ 0       $ 0       $ 0 $ 0 $ 0